Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
21 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Sonoma Pharmaceuticals, Inc.’s names, not what it holds today.
Patents granted
21
21 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
30
since 2001, to Dec 31, 2025
Names they are printed under
3
a former name, its own name
By yearGrantedApplications published
'05'06'07'08'10'11'12'14'15'16'17'18'19'20
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name3 counted
Oculus Innovative Sciences, Inc. a former name
US, as the owner printed on each patent
24 publishedSonoma Pharmaceuticals, Inc. its own name
US, as the owner printed on each patent
3 publishedOculus Innovative Sciences, Inc. a former name
named as the applicant on its applications, in US
3 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Apr 14, 2020 | 10,617,715 | Methods of treating or preventing biofilm associated infections with free available chlorine free available chlorine water | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Sep 17, 2019 | 10,412,969 | Stabilized hypochlorous acid solution and use thereof | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Jul 9, 2019 | 10,342,825 | Solution containing hypochlorous acid and methods of using same | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Apr 23, 2019 | 10,265,341 | Hydrogel formulation comprising oxidative reductive potential water | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Jul 10, 2018 | 10,016,455 | Method of preventing or treating influenza with oxidative reductive potential water solution | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Mar 20, 2018 | 9,918,477 | Stabilized hypochlorous acid solution and use thereof | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Oct 10, 2017 | 9,782,434 | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| May 9, 2017 | 9,642,876 | Method of preventing or treating sinusitis with oxidative reductive potential water solution | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Nov 22, 2016 | 9,498,548 | Method of using oxidative reductive potential water solution in dental applications | Medical technology | Oculus Innovative Sciences, Inc. |
| Nov 8, 2016 | 9,486,479 | Antimicrobial solutions containing dichloride monoxide and methods of making and using the same | Pharmaceuticals | Oculus Innovative Sciences, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jul 26, 2018 | 2018/0206502 | STABILIZED HYPOCHLOROUS ACID SOLUTION AND USE THEREOF | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. · patent 10,412,969 granted from it |
| Feb 1, 2018 | 2018/0028562 | METHODS OF TREATING OR PREVENTING INFLAMMATION AND HYPERSENSITIVITY WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. |
| Aug 24, 2017 | 2017/0239291 | METHOD OF PREVENTING OR TREATING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | Pharmaceuticals | Sonoma Pharmaceuticals, Inc. · patent 10,016,455 granted from it |
| Mar 16, 2017 | 2017/0071980 | METHOD OF USING OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION IN DENTAL APPLICATIONS | Medical technology | Oculus Innovative Sciences, Inc. |
| Feb 23, 2017 | 2017/0049813 | ANTIMICROBIAL SOLUTIONS CONTAINING DICHLORINE MONOXIDE AND METHODS OF MAKING AND USING THE SAME | Pharmaceuticals | Oculus Innovative Sciences, Inc. |
| May 5, 2016 | 2016/0120183 | STABILIZED HYPOCHLOROUS ACID SOLUTION AND USE THEREOF | Pharmaceuticals | Oculus Innovative Sciences, Inc. · patent 9,918,477 granted from it |
| Feb 18, 2016 | 2016/0045547 | METHOD OF PREVENTING OR TREATING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | Pharmaceuticals | Oculus Innovative Sciences, Inc. · patent 9,642,876 granted from it |
| Oct 29, 2015 | 2015/0306137 | METHODS OF TREATING OR PREVENTING INFLAMMATION AND HYPERSENSITIVITY WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | Pharmaceuticals | Oculus Innovative Sciences, Inc. · patent 9,782,434 granted from it |
| Oct 8, 2015 | 2015/0283107 | METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID AND INOSITOL | Pharmaceuticals | Oculus Innovative Sciences, Inc. · patent 9,259,410 granted from it |
| Nov 6, 2014 | 2014/0328946 | ANTIMICROBIAL SOLUTIONS CONTAINING DICHLORIDE MONOXIDE AND METHODS OF MAKING AND USING THE SAME | Pharmaceuticals | Oculus Innovative Sciences, Inc. · patent 9,486,479 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.